CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C02504 | BRD-K00362189 | BRD-K00362189 | -- | -- | -- | Details |
| C02505 | BRD-K00363054 | BRD-K00363054 | -- | -- | -- | Details |
| C02506 | BRD-K00366212 | BRD-K00366212 | -- | -- | -- | Details |
| C02507 | BRD-K00377328 | BRD-K00377328 | -- | -- | -- | Details |
| C02508 | BRD-K00378498 | BRD-K00378498 | -- | -- | -- | Details |
| C02509 | BRD-K00381581 | BRD-K00381581 | -- | -- | -- | Details |
| C02510 | BRD-K00381858 | BRD-K00381858 | -- | -- | -- | Details |
| C02511 | BRD-K00382464 | BRD-K00382464 | -- | -- | -- | Details |
| C02512 | BRD-K00384875 | BRD-K00384875 | -- | -- | -- | Details |
| C02513 | BRD-K00390580 | BRD-K00390580 | -- | -- | -- | Details |
| C02514 | BRD-K00391235 | BRD-K00391235 | -- | -- | -- | Details |
| C02515 | BRD-K00398667 | BRD-K00398667 | -- | -- | -- | Details |
| C02516 | BRD-K00401259 | BRD-K00401259 | -- | -- | -- | Details |
| C02517 | BRD-K00403046 | BRD-K00403046 | -- | -- | -- | Details |
| C02518 | BRD-K00409424 | BRD-K00409424 | -- | -- | -- | Details |
| C02519 | BRD-K00409771 | BRD-K00409771 | -- | -- | -- | Details |
| C02520 | BRD-K00411149 | BRD-K00411149 | -- | -- | -- | Details |
| C02521 | BRD-K00411687 | BRD-K00411687 | -- | -- | -- | Details |
| C02522 | BRD-K00412766 | BRD-K00412766 | -- | -- | -- | Details |
| C02523 | BRD-K00414849 | BRD-K00414849 | -- | -- | -- | Details |
| C02524 | BRD-K00418890 | BRD-K00418890 | -- | -- | -- | Details |
| C02525 | BRD-K00422823 | BRD-K00422823 | -- | -- | -- | Details |
| C02526 | BRD-K00423214 | BRD-K00423214 | -- | -- | -- | Details |
| C02527 | BRD-K00423995 | BRD-K00423995 | -- | -- | -- | Details |
| C02528 | BRD-K00429057 | BRD-K00429057 | -- | -- | -- | Details |
| C02529 | BRD-K00430421 | BRD-K00430421 | -- | -- | -- | Details |
| C02530 | BRD-K00431438 | BRD-K00431438 | -- | -- | -- | Details |
| C02531 | BRD-K00434250 | BRD-K00434250 | -- | -- | -- | Details |
| C02532 | BRD-K00436546 | BRD-K00436546 | -- | -- | -- | Details |
| C02533 | BRD-K00442147 | BRD-K00442147 | -- | -- | -- | Details |
| C02534 | BRD-K00445923 | BRD-K00445923 | -- | -- | -- | Details |
| C02535 | BRD-K00446585 | BRD-K00446585 | -- | -- | -- | Details |
| C02536 | BRD-K00449983 | BRD-K00449983 | -- | -- | -- | Details |
| C02537 | BRD-K00458136 | BRD-K00458136 | -- | -- | -- | Details |
| C02538 | BRD-K00462298 | BRD-K00462298 | -- | -- | -- | Details |
| C02539 | BRD-K00463020 | BRD-K00463020 | -- | -- | -- | Details |
| C02540 | BRD-K00463125 | BRD-K00463125 | -- | -- | -- | Details |
| C02541 | BRD-K00468432 | BRD-K00468432 | -- | -- | -- | Details |
| C02542 | BRD-K00472408 | BRD-K00472408 | -- | -- | -- | Details |
| C02543 | BRD-K00474848 | BRD-K00474848 | -- | -- | -- | Details |
| C02544 | BRD-K00478394 | BRD-K00478394 | -- | -- | -- | Details |
| C02545 | BRD-K00480552 | BRD-K00480552 | -- | -- | -- | Details |
| C02546 | BRD-K00484200 | BRD-K00484200 | -- | -- | -- | Details |
| C02547 | BRD-K00486725 | BRD-K00486725 | -- | -- | -- | Details |
| C02548 | BRD-K00486786 | Ro-08-2750 | NGF; NGFR | NGF binding inhibitor | -- | Details |
| C02549 | BRD-K00494077 | trovafloxacin | -- | -- | -- | Details |
| C02550 | BRD-K00498462 | BRD-K00498462 | -- | -- | -- | Details |
| C02551 | BRD-K00502422 | BRD-K00502422 | -- | -- | -- | Details |
| C02552 | BRD-K00502656 | BRD-K00502656 | -- | -- | -- | Details |
| C02553 | BRD-K00504156 | BRD-K00504156 | -- | -- | -- | Details |
| C02554 | BRD-K00505499 | BRD-K00505499 | -- | -- | -- | Details |
| C02555 | BRD-K00505809 | BRD-K00505809 | -- | -- | -- | Details |
| C02556 | BRD-K00507184 | BRD-K00507184 | -- | -- | -- | Details |
| C02557 | BRD-K00509183 | BRD-K00509183 | -- | -- | -- | Details |
| C02558 | BRD-K00509345 | BRD-K00509345 | -- | -- | -- | Details |
| C02559 | BRD-K00513921 | BRD-K00513921 | -- | -- | -- | Details |
| C02560 | BRD-K00518397 | BRD-K00518397 | -- | -- | -- | Details |
| C02561 | BRD-K00521308 | ATN-161 | ITGA5; ITGAV; ITGB1; ITGB3 | Integrin inhibitor | -- | Details |
| C02562 | BRD-K00526921 | BRD-K00526921 | -- | -- | -- | Details |
| C02563 | BRD-K00530465 | BRD-K00530465 | -- | -- | -- | Details |
| C02564 | BRD-K00532621 | midazolam | -- | -- | -- | Details |
| C02565 | BRD-K00537235 | BRD-K00537235 | -- | -- | -- | Details |
| C02566 | BRD-K00540336 | BRD-K00540336 | -- | -- | -- | Details |
| C02567 | BRD-K00541156 | BRD-K00541156 | -- | -- | -- | Details |
| C02568 | BRD-K00541818 | BRD-K00541818 | -- | -- | -- | Details |
| C02569 | BRD-K00542622 | BRD-K00542622 | -- | -- | -- | Details |
| C02570 | BRD-K00544996 | BRD-K00544996 | -- | -- | -- | Details |
| C02571 | BRD-K00547540 | BRD-K00547540 | -- | -- | -- | Details |
| C02572 | BRD-K00549770 | BRD-K00549770 | -- | -- | -- | Details |
| C02573 | BRD-K00549983 | BRD-K00549983 | -- | -- | -- | Details |
| C02574 | BRD-K00550058 | BRD-K00550058 | -- | -- | -- | Details |
| C02575 | BRD-K00551139 | BRD-K00551139 | -- | -- | -- | Details |
| C02576 | BRD-K00551481 | BRD-K00551481 | -- | -- | -- | Details |
| C02577 | BRD-K00554047 | BRD-K00554047 | -- | -- | -- | Details |
| C02578 | BRD-K00555438 | BRD-K00555438 | -- | -- | -- | Details |
| C02579 | BRD-K00557942 | BRD-K00557942 | -- | -- | -- | Details |
| C02580 | BRD-K00562490 | BRD-K00562490 | -- | -- | -- | Details |
| C02581 | BRD-K00566460 | BRD-K00566460 | -- | -- | -- | Details |
| C02582 | BRD-K00566471 | BRD-K00566471 | -- | -- | -- | Details |
| C02583 | BRD-K00568440 | BRD-K00568440 | -- | -- | -- | Details |
| C02584 | BRD-K00573290 | BRD-K00573290 | -- | -- | -- | Details |
| C02585 | BRD-K00573984 | delapril | ACE | Angiotensin converting enzyme inhibitor | -- | Details |
| C02586 | BRD-K00575273 | BRD-K00575273 | -- | -- | -- | Details |
| C02587 | BRD-K00575615 | BRD-K00575615 | -- | -- | -- | Details |
| C02588 | BRD-K00585841 | BRD-K00585841 | -- | -- | -- | Details |
| C02589 | BRD-K00586388 | BRD-K00586388 | -- | -- | -- | Details |
| C02590 | BRD-K00586442 | BRD-K00586442 | -- | -- | -- | Details |
| C02591 | BRD-K00590556 | BRD-K00590556 | -- | -- | -- | Details |
| C02592 | BRD-K00591281 | BRD-K00591281 | -- | -- | -- | Details |
| C02593 | BRD-K00596555 | BRD-K00596555 | -- | -- | -- | Details |
| C02594 | BRD-K00596708 | BRD-K00596708 | -- | -- | -- | Details |
| C02595 | BRD-K00598313 | BRD-K00598313 | -- | -- | -- | Details |
| C02596 | BRD-K00600835 | BRD-K00600835 | -- | -- | -- | Details |
| C02597 | BRD-K00603606 | ticlopidine | P2RY12 | Purinergic receptor antagonist | -- | Details |
| C02598 | BRD-K00610438 | altanserin | HTR2A | Serotonin receptor antagonist | -- | Details |
| C02599 | BRD-K00610900 | BRD-K00610900 | -- | -- | -- | Details |
| C02600 | BRD-K00611064 | BRD-K00611064 | -- | -- | -- | Details |
| C02601 | BRD-K00611112 | BRD-K00611112 | -- | -- | -- | Details |
| C02602 | BRD-K00615600 | AG-14361 | PARP1 | PARP inhibitor | -- | Details |
| C02603 | BRD-K00620786 | BRD-K00620786 | -- | -- | -- | Details |